These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3134513

  • 21. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
    Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU.
    Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of various malignancies with recombinant IFN-gamma (S-6810). The IFN-gamma Study Group].
    Takaku F.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):645-52. PubMed ID: 3030197
    [Abstract] [Full Text] [Related]

  • 23. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA, Grunberg SM, Daniels JR, Skinner DG, Venturi CL, Spiegel R, Neri R, Greiner JM, Rudnick S, Mitchell MS.
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [Abstract] [Full Text] [Related]

  • 24. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Feb; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

  • 27. Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.
    Kolitz JE, Wong GY, Welte K, Merluzzi VJ, Engert A, Bialas T, Polivka A, Bradley EC, Konrad M, Gnecco C.
    J Biol Response Mod; 1988 Oct; 7(5):457-72. PubMed ID: 3263471
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously.
    Whitehead RP, Friedman KD, Clark DA, Pagani K, Rapp L.
    Clin Cancer Res; 1995 Oct; 1(10):1145-52. PubMed ID: 9815906
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
    van der Burg M, Edelstein M, Gerlis L, Liang CM, Hirschi M, Dawson A.
    J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
    [Abstract] [Full Text] [Related]

  • 35. [Gamma interferon therapy of cancer patients].
    Kobayashi Y, Urabe A.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):804-9. PubMed ID: 3133983
    [Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetics of intratumoral interferon-gamma activity following subcutaneous administration of recombinant interferon-gamma in a patient with metastatic brain tumor derived from renal cancer].
    Yamasaki T, Kagawa T, Takamura M, Moritake K.
    No Shinkei Geka; 1995 Feb; 23(2):169-73. PubMed ID: 7877739
    [Abstract] [Full Text] [Related]

  • 37. Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.
    Bennett CL, Vogelzang NJ, Ratain MJ, Reich SD.
    Cancer Treat Rep; 1986 Sep; 70(9):1081-4. PubMed ID: 3091246
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
    Creagan ET, Ahmann DL, Long HJ, Frytak S, Sherwin SA, Chang MN.
    Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.